pregnanolone has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| El-Kott, AF; El-Maksoud, MMA; Fu, M; Ji, C; Ji, Y; Mao, F; Negm, S; Shati, AA; Yang, T | 1 |
| Camacho-Arroyo, I; Zamora-Sánchez, CJ | 1 |
2 review(s) available for pregnanolone and Neoplasms
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer.
Topics: Gonadal Steroid Hormones; Humans; Neoplasms; Pregnanolone; Progesterone; Receptors, Progesterone | 2022 |
1 other study(ies) available for pregnanolone and Neoplasms
| Article | Year |
|---|---|
Anti-ovarian cancer potential, in silico studies, and anti-Alzheimer's disease effects of some natural compounds as cholinesterase inhibitors.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Female; Humans; Molecular Docking Simulation; Neoplasms; Pregnanolone | 2023 |